A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer

被引：0
|
作者：
Li, Y. [1 ]
Xing, L. [1 ]
Yin, X. [1 ]
Li, H. [1 ]
Ren, G. [1 ]
机构：
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.03.082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68P
引用
收藏
页码：S50 / S51
页数：2
相关论文
共 50 条
  • [31] Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients
    Nishio, Minako
    Kojitani, Yoshiki
    Kitashiro, Saya
    Ishiduka, Yasunobu
    Otsuka, Tomoyuki
    Nishida, Naohiro
    Fujisawa, Fumie
    Sugimoto, Naotoshi
    Yagi, Toshinari
    Souma, Ai
    Kanaoka, Haruka
    Oyamayama, Yuri
    Taniguchi, Azusa
    Nakajima, Satomi
    Seto, Yukiko
    Kusama, Hiroki
    Watanabe, Noriyuki
    Matsui, Saki
    Nakayama, Takahiro
    Kudou, Toshihiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1465 - S1465
  • [32] Window of opportunity trials with immune checkpoint inhibitors in triple-negative breast cancer
    Quintana, A.
    Saini, K. S.
    Vidal, L.
    Peg, V.
    Slebe, F.
    Loibl, S.
    Curigliano, G.
    Schmid, P.
    Cortes, J.
    ESMO OPEN, 2024, 9 (10)
  • [33] The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
    Singh, Sima
    Numan, Arshid
    Maddiboyina, Balaji
    Arora, Saahil
    Riadi, Yassine
    Md, Shadab
    Alhakamy, Nabil A.
    Kesharwani, Prashant
    DRUG DISCOVERY TODAY, 2021, 26 (07) : 1721 - 1727
  • [34] Efficacy and Safety of PD-1/PD-L1 Inhibitors in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
    Li, Zhen-Yu
    Zhang, Zhen
    Cao, Xiao-Zhong
    Feng, Yun
    Ren, Sha-Sha
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2023, 50 (09):
  • [35] Predictive value of PD-L1 expression to the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer: A systematic review and meta-analysis
    Qi, Yingjie
    Yan, Xin
    Wang, Chao
    Cao, Hui
    Liu, Guangxuan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
    Wu, Kunpeng
    Yang, Qiaozhu
    Liu, Yi
    Wu, Aibing
    Yang, Zhixiong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [37] Neoadjuvant immunotherapy plus chemotherapy in early triple-negative breast cancer: A meta-analysis of randomized controlled trials
    Pandy, J. G. P.
    Alcantara, M. J. E.
    Ordinario, M. V.
    Li, R. K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1245 - S1246
  • [38] Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
    Kunpeng Wu
    Qiaozhu Yang
    Yi Liu
    Aibing Wu
    Zhixiong Yang
    World Journal of Surgical Oncology, 12
  • [39] Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
    Weng, Zeng-Jie
    Wu, Sheng-Xi
    Luo, He-San
    Du, Ze-Sen
    Li, Xu-Yuan
    Lin, Jia-Zhou
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2021, 58
  • [40] Neoadjuvant immunotherapy plus chemotherapy in early triple-negative breast cancer: A meta-analysis of randomized controlled trials
    Pandy, J. G. P.
    Ordinario, M. V. C.
    Alcantara, M. J. E.
    Li, R. K.
    ANNALS OF ONCOLOGY, 2020, 31 : S320 - S320
12345